These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24647901)

  • 1. Detection and quantitation of glutamate carboxypeptidase II in human blood.
    Knedlík T; Navrátil V; Vik V; Pacík D; Šácha P; Konvalinka J
    Prostate; 2014 May; 74(7):768-80. PubMed ID: 24647901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glutamate carboxypeptidase II in human brain.
    Sácha P; Zámecník J; Barinka C; Hlouchová K; Vícha A; Mlcochová P; Hilgert I; Eckschlager T; Konvalinka J
    Neuroscience; 2007 Feb; 144(4):1361-72. PubMed ID: 17150306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
    Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
    J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
    Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
    Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
    Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
    Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
    Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
    J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme.
    Alt J; Stathis M; Rojas C; Slusher B
    FASEB J; 2013 Jul; 27(7):2620-5. PubMed ID: 23525278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
    Sedlák F; Kvasnička A; Marešová B; Brumarová R; Dobešová D; Dostálová K; Šrámková K; Pehr M; Šácha P; Friedecký D; Konvalinka J
    ACS Chem Neurosci; 2024 Apr; 15(7):1342-1355. PubMed ID: 38377674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
    Urazaev AK; Grossfeld RM; Lieberman EM
    J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
    Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
    J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.
    Mesters JR; Barinka C; Li W; Tsukamoto T; Majer P; Slusher BS; Konvalinka J; Hilgenfeld R
    EMBO J; 2006 Mar; 25(6):1375-84. PubMed ID: 16467855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.
    Bařinka C; Rojas C; Slusher B; Pomper M
    Curr Med Chem; 2012; 19(6):856-70. PubMed ID: 22214450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.
    Naushad SM; Shree Divyya P; Janaki Ramaiah M; Alex Stanley B; Prasanna Lakshmi S; Vishnupriya J; Kutala VK
    Cancer Genet; 2015 Nov; 208(11):552-8. PubMed ID: 26471812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).
    Tykvart J; Navrátil V; Sedlák F; Corey E; Colombatti M; Fracasso G; Koukolík F; Bařinka C; Sácha P; Konvalinka J
    Prostate; 2014 Dec; 74(16):1674-90. PubMed ID: 25262926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications.
    Neale JH; Yamamoto T
    Prog Neurobiol; 2020 Jan; 184():101722. PubMed ID: 31730793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of human glutamate carboxypeptidase III.
    Hlouchová K; Barinka C; Klusák V; Sácha P; Mlcochová P; Majer P; Rulísek L; Konvalinka J
    J Neurochem; 2007 May; 101(3):682-96. PubMed ID: 17241121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.
    Nguyen T; Kirsch BJ; Asaka R; Nabi K; Quinones A; Tan J; Antonio MJ; Camelo F; Li T; Nguyen S; Hoang G; Nguyen K; Udupa S; Sazeides C; Shen YA; Elgogary A; Reyes J; Zhao L; Kleensang A; Chaichana KL; Hartung T; Betenbaugh MJ; Marie SK; Jung JG; Wang TL; Gabrielson E; Le A
    Cell Rep; 2019 Apr; 27(2):491-501.e6. PubMed ID: 30970252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding.
    Barinka C; Mlcochová P; Sácha P; Hilgert I; Majer P; Slusher BS; Horejsí V; Konvalinka J
    Eur J Biochem; 2004 Jul; 271(13):2782-90. PubMed ID: 15206943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue expression and enzymologic characterization of human prostate specific membrane antigen and its rat and pig orthologs.
    Rovenská M; Hlouchová K; Sácha P; Mlcochová P; Horák V; Zámecník J; Barinka C; Konvalinka J
    Prostate; 2008 Feb; 68(2):171-82. PubMed ID: 18076021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury.
    Gao Y; Xu S; Cui Z; Zhang M; Lin Y; Cai L; Wang Z; Luo X; Zheng Y; Wang Y; Luo Q; Jiang J; Neale JH; Zhong C
    J Neurochem; 2015 Jul; 134(2):340-53. PubMed ID: 25872793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.